Zenopsys is the AI platform for authoring, reviewing, and submitting every document across drug development — clinical protocols, CSRs, and full eCTD dossiers (IND, ANDA, NDA, MAA). Built for pharma innovators, generics manufacturers, and regulatory consultants worldwide.
Book a Demo

Trusted by the India's leading Life Sciences Companies
Outcomes That Redefine Regulatory Efficiency


10× Faster Documentation Cycles
Accelerate end-to-end documentation cycles by reducing rework, streamlining reviews, and keeping content aligned.


First Drafts in Minutes, Not Weeks
Generate complete, structured first drafts in minutes, eliminating weeks of manual authoring and setup.


99.9% Reduction in Errors
Significantly reduce errors through consistent structure, traceability, and built-in quality checks across documentation.
Capabilities That Bring Structure to Regulatory Work
Designed for Enterprise Trust and Control
Industries we support
Supporting regulatory work across life sciences
Investors & advisors
Backed by experienced operators and domain experts

Anand Ekambaram
Ex. Merck, BMS
Advisor

Dr. Jayanth Sridhar
CEO, Biologics, Dr. Reddy's
Investor & Advisor

Venkat Kamalakar
CEO, Garphi Biosciences
Investor & Advisor

Dr. Mahesh Bhalgat
CEO, Veeda LifeSciences
Advisor


Book a Demo
























